In breast and prostate cancers, SPRY4 can inhibit cell proliferation and migration (Jing et al.2016; Vanas et al.2014; Wang et al.2006), while in ovarian cancer, SPRY4 promotes ovarian cancer invasion (So et al.2016). This evidence concerns the gene SPRY4 and ovarian cancer.